Clinical Trial

To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery

Study acronym: TRD205
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2025 (before its estimated December 27, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, double-blind, placebo-controlled phase Ib study designed to evaluate the safety, efficacy and PK of TRD205 tablets administered orally .
Trial Details
NCT Number NCT07121023
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Collaborators: Beijing Jishuitan Hospital
Conditions Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery
Enrollment 32 participants
Start Date 2025-08-26
Primary Completion 2025-12-27 (estimated)
Study Completion 2025-12-27 (estimated)
Updated on ClinicalTrials.gov 2025-08-13